NCRI Press Release, 9 November 2016
Marker for aggressive prostate cancer doubles-up as a drug target
Download the attachmentRecent Tweets
-
RT @Bloodwise_res : Registration is now open for the first joint @NCRI_partners and @NHSEngland Living With and Beyond Blood Cancer event, t…
1 day ago -
As part of our work to translate the #LivingWithandBeyondCancer research priorities into patient benefit we're plea… https://t.co/NQ3nfGQhBC
2 days ago -
RT @DrIanto : This is more great news, well done to everyone driving this forward. It feels like we’re now getting to a place where we can r…
1 week ago
RSS Feed